The Wistar Institute, the Pennsylvania Biotechnology Center, and the Baruch S. Blumberg Institute formed a collaboration to accelerate the advancement of “bench to bedside” biomedical research discoveries in Pennsylvania, New Jersey, and Delaware by collectively supporting the seeding, launching, and maturation of life science startups.
The Wistar Institute is collaborating with Accelerated Biosciences Corp. to create a platform based on human trophoblast stem cells to explore new immunotherapies that use Accelerated Bio’s proprietary technology. This collaboration could generate various types of immune cells from hTSCs, changing the field of allogeneic immunotherapies.
